To this aim, we treated parental PCa and PCaRR cells with increasing doses of Docetaxel for 24 and 48 h, and then we performed flow cytometry analysis by Annexin-V/PI staining to evaluate the apoptotic/necrotic cell percentage. This evidence concerns the gene ANXA5 and posterior cortical atrophy.